EW · Edwards Lifesciences Corp · Webcasts, Transcripts & Audio
$107.15
+1.35 (+1.28%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$61.61B
Shares
575.00M
Volume · Nov 13
3.82M
Avg daily vol (3M)
3.81M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Edwards Lifesciences Corp Webcasts
Earnings calls, investor updates, investor days and conferences for Edwards Lifesciences Corp (EW), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-12-04
Edwards Lifesciences Corp (EW) December 4, 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q3
2026-11-04
Edwards Lifesciences Corp (EW) Q3 2026 Earnings Call
Revenue
$1.72B
▲ 10.5% YoY Diluted EPS
$0.53
▲ 6% YoY Gross margin
78.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-07-23
Edwards Lifesciences Corp (EW) Q2 2026 Earnings Call Transcript
Confident tone
TAVR franchise and Sapien platform
PROGRESS trial readout
TMTT (Pascal, Evoque, SAPIEN M3) momentum
Revenue
$1.74B
▲ 13.6% YoY Diluted EPS
$0.42
▼ 25% YoY Gross margin
77.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-05-12
Edwards Lifesciences Corp (EW) May 12, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-04-23
Edwards Lifesciences Corp (EW) Q1 2026 Earnings Call Transcript
Confident tone
TAVR growth and market momentum
TMTT (mitral and tricuspid) portfolio
Surgical structural heart
Revenue
$1.65B
▲ 16.7% YoY Diluted EPS
$0.66
▲ 8.2% YoY Gross margin
78.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-03-10
Edwards Lifesciences Corp (EW) March 10, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-02-10
Edwards Lifesciences Corp (EW) Q4 2025 Earnings Call Transcript
Confident tone
TAVR Growth Momentum and Durability Data
Early TAVR and Asymptomatic Indication
TMTT Portfolio Expansion
Revenue
$1.57B*
▲ 13.3% YoY Gross margin
78.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-30
Edwards Lifesciences Corp (EW) Q3 2025 Earnings Call Transcript
Confident tone
TAVR franchise growth and clinical evidence
TMTT (Mitral and Tricuspid) portfolio expansion
R&D discipline and margin expansion
Revenue
$1.55B
▲ 14.7% YoY Diluted EPS
$0.50
▼ 90.3% YoY Gross margin
77.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-24
Edwards Lifesciences Corp (EW) Q2 2025 Earnings Call Transcript
Confident tone
TAVR growth and SAPIEN platform
TMTT (mitral/tricuspid) franchise leadership
TAVR leadership transition
Revenue
$1.53B
▲ 11.9% YoY Diluted EPS
$0.56
▼ 8.2% YoY Gross margin
77.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-23
Edwards Lifesciences Corp (EW) Q1 2025 Earnings Call Transcript
Confident tone
TMTT momentum and product approvals
Tariffs and financial guidance
TAVR growth and early TAVR expansion
Revenue
$1.41B
▲ 6.2% YoY Diluted EPS
$0.61
▲ 5.2% YoY Gross margin
78.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-11
Edwards Lifesciences Corp (EW) Q4 2024 Earnings Call Transcript
Confident tone
TMTT (mitral and tricuspid) momentum
TAVR growth and early TAVR catalyst
2025 financial guidance and outlook
Revenue
$1.39B
▲ 9.4% YoY Diluted EPS
$0.65
▲ 6.6% YoY Gross margin
78.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-24
Edwards Lifesciences Corp (EW) Q3 2024 Earnings Call Transcript
Confident tone
TAVR performance and outlook
TMTT growth (PASCAL, EVOQUE, SAPIEN M3)
Portfolio reshaping and Critical Care divestiture
Revenue
$1.35B
▲ 8.9% YoY Diluted EPS
$5.13
▲ 714.3% YoY Gross margin
80.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-24
Edwards Lifesciences Corp (EW) Q2 2024 Earnings Call Transcript
Cautious tone
TAVR sales shortfall and US hospital workflow pressure
TMTT growth and product launches
JenaValve and Endotronix acquisitions
Revenue
$1.37B
▲ 7.1% YoY Diluted EPS
$0.61
▲ 22% YoY Gross margin
79.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-04-25
Edwards Lifesciences Corp (EW) Q1 2024 Earnings Call Transcript
Confident tone
TAVR growth and SAPIEN platform
TMTT (mitral and tricuspid) growth
Critical Care spin-off
Revenue
$1.33B
▲ 8.9% YoY Diluted EPS
$0.58
▲ 3.6% YoY Gross margin
78.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-06
Edwards Lifesciences Corp (EW) Q4 2023 Earnings Call Transcript
Confident tone
TAVR growth and leadership
TMTT portfolio expansion
EVOQUE FDA approval and launch
Revenue
$1.27B
▲ 194.6% YoY Diluted EPS
$0.61
Gross margin
80.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-10-25
Edwards Lifesciences Corp (EW) Q3 2023 Earnings Call Transcript
Revenue
$1.24B
▼ 5.7% YoY Diluted EPS
$0.63
▲ 14.5% YoY Gross margin
79.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-07-26
Edwards Lifesciences Corp (EW) Q2 2023 Earnings Call Transcript
Revenue
$1.28B
▼ 6.9% YoY Diluted EPS
$0.50
▼ 23.1% YoY Gross margin
80.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-04-26
Edwards Lifesciences Corp (EW) Q1 2023 Earnings Call Transcript
Revenue
$1.22B
▼ 8.9% YoY Diluted EPS
$0.56
▼ 5.1% YoY Gross margin
81.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-01-31
Edwards Lifesciences Corp (EW) Q4 2022 Earnings Call Transcript
Revenue
$429.90M*
▼ 67.7% YoY Gross margin
123.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-10-27
Edwards Lifesciences Corp (EW) Q3 2022 Earnings Call Transcript
Revenue
$1.32B
▲ 0.7% YoY Diluted EPS
$0.55
▲ 1.9% YoY Gross margin
80.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-07-28
Edwards Lifesciences Corp (EW) Q2 2022 Earnings Call Transcript
Revenue
$1.37B
▼ 0.2% YoY Diluted EPS
$0.65
▼ 16.7% YoY Gross margin
80.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-26
Edwards Lifesciences Corp (EW) Q1 2022 Earnings Call Transcript
Revenue
$1.34B
▲ 10.2% YoY Diluted EPS
$0.59
▲ 9.3% YoY Gross margin
77.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-01-26
Edwards Lifesciences Corp (EW) Q4 2021 Earnings Call Transcript
Revenue
$1.33B*
▲ 11.6% YoY Gross margin
76.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-10-27
Edwards Lifesciences Corp (EW) Q3 2021 Earnings Call Transcript
Revenue
$1.31B
▲ 14.8% YoY Diluted EPS
$0.54
▲ 3.8% YoY Gross margin
76.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-29
Edwards Lifesciences Corp (EW) Q2 2021 Earnings Call Transcript
Revenue
$1.38B
▲ 48.8% YoY Diluted EPS
$0.78
Gross margin
75.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-20
Edwards Lifesciences Corp (EW) Q1 2021 Earnings Call Transcript
Revenue
$1.22B
▲ 7.8% YoY Diluted EPS
$0.54
▲ 10.2% YoY Gross margin
75.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-01-27
Edwards Lifesciences Corp (EW) Q4 2020 Earnings Call Transcript
Revenue
$1.19B
▲ 1.5% YoY Diluted EPS
$0.49
▲ 11.4% YoY Gross margin
75.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-21
Edwards Lifesciences Corp (EW) Q3 2020 Earnings Call Transcript
Revenue
$1.14B
▲ 4.3% YoY Diluted EPS
$0.52
▲ 20.9% YoY Gross margin
75.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-23
Edwards Lifesciences Corp (EW) Q2 2020 Earnings Call Transcript
Revenue
$925.00M
▼ 14.9% YoY Diluted EPS
$-0.20
▼ 152.6% YoY Gross margin
74.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-23
Edwards Lifesciences Corp (EW) Q1 2020 Earnings Call Transcript
Revenue
$1.13B
▲ 13.7% YoY Diluted EPS
$0.49
▲ 25.6% YoY Gross margin
76.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-01-30
Edwards Lifesciences Corp (EW) Q4 2019 Earnings Call
Revenue
$1.17B
▲ 20.1% YoY Diluted EPS
$0.44
▲ 4300% YoY Gross margin
75.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–31 of 31 webcasts
Key facts
CIK
1099800
CUSIP
28176E108
13F (30d)
1090 filings
1004 filers
Visit website
Investor relations